Application-based Medical Thermometers segmentation structures demand into four clinically distinct pockets: hospitals, ambulatory surgical centers (ASCs), home care, and clinics. Hospitals remain the dominant channel, commanding roughly 48 % of 2023 global revenue, driven by high throughput, mandatory electronic medical-record integration, and stringent ±0.1 °C accuracy mandates that favour premium infrared or predictive probe models. ASCs, though smaller, exhibit the fastest unit-growth as outpatient volumes rise; their purchasing is price-elastic but insists on single-use probe covers to minimise cross-contamination risk. Home care now represents 26 % of dollar sales, up from 19 % in 2019, catalysed by reimbursement for tele-health bundles and consumer preference for no-contact infrared thermometers; gross margins here compress due to private-label penetration but volumes offset dilution. Clinics sit between institutional and home settings, typically procuring mid-tier digital stick units through group-purchasing organisations, accounting for the residual share. Collectively, these application strata explain why unit shipments outpace revenue growth: the mix is shifting toward lower-priced SKUs in high-volume, non-institutional endpoints.